Michael Bergmann
- Reproductive Medicine top 1%
- Sperm and Testicular Function 20
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 19
- Virus-based gene therapy research 13
- Immunology top 2%
- Immune Cell Function and Interaction 12
- Immune cells in cancer 11
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 18
- Colorectal Cancer Surgical Treatments 14
-
- Lymphoma Diagnosis and Treatment 14
- Co-authors
- Thomas MusterT. ByersDavid S. FreedmanAli H. MokdadAdolfo Garcı́a-SastreMichael HallekPeter PaleseThomas Sautner
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Michael Bergmann
248 papers receiving 6.6k citations
Peers
Comparison fields: 5 of 186
- Reproductive Medicine 705
- Genetics 727
- Immunology 1.3k
- Oncology 1.3k
- Pathology and Forensic Medicine 689
Countries citing papers authored by Michael Bergmann
This map shows the geographic impact of Michael Bergmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bergmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bergmann more than expected).
Fields of papers citing papers by Michael Bergmann
This network shows the impact of papers produced by Michael Bergmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bergmann. The network helps show where Michael Bergmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Bergmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 13 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 17 | |
| 6 | 2023 | 31 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 18 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 14 | |
| 11 | 2020 | 22 | |
| 12 | 2019 | 17 | |
| 13 | 2018 | 5 | |
| 14 | 2017 | 39 | |
| 15 | 2014 | 2 | |
| 16 | Muskelbiopsie: Indikationen und Technik | 2009 | 1 |
| 17 | Fludarabine induces higher response rates in first line therapy of older patients with advanced chronic lymphocytic leukemia than chlorambucil Interim analysis of a phase III study of the German CLL Study Group | 2003 | 9 |
| 18 | Fludarabine, Mitoxantrone and Cyclophosphamide Combination Therapy in Relapsed Chronic Lymphocytic Leukemia with or without G-CSF Results of the First Interim Ananlysis of a Phase III Study of the German CLL Study Group | 2002 | 3 |
| 19 | Ultrafast optical measurements on InGaN multiple quantum wells | 2000 | 0 |
| 20 | 1998 | 318 |
About Michael Bergmann
Michael Bergmann is a scholar working on Immunology, Reproductive Medicine and Oncology, having authored 268 papers that have together received 6.8k indexed citations. Recurring topics across this work include Sperm and Testicular Function (20 papers), Chronic Lymphocytic Leukemia Research (19 papers), Cancer Immunotherapy and Biomarkers (18 papers), Lymphoma Diagnosis and Treatment (14 papers), Colorectal Cancer Surgical Treatments (14 papers), Virus-based gene therapy research (13 papers), Immune Cell Function and Interaction (12 papers) and Immune cells in cancer (11 papers). The work is most often cited by research in Reproductive Medicine (705 citations), Genetics (727 citations) and Immunology (1.3k citations). Michael Bergmann has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Thomas Muster, T. Byers, David S. Freedman, Ali H. Mokdad, Adolfo Garcı́a-Sastre, Michael Hallek, Peter Palese, Thomas Sautner, Hubert Pehamberger and Klaus Wolff. Their work appears in journals such as PLoS ONE, Blood, Human Reproduction, International Journal of Andrology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.